Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

survivin

  • You have access
    YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression
    TAKESHI MIYAO, HIDEKAZU KOIKE, YOSHITAKA SEKINE, AKIRA OHTSU, DAISUKE OKA and KAZUHIRO SUZUKI
    Anticancer Research September 2020, 40 (9) 5091-5095; DOI: https://doi.org/10.21873/anticanres.14512
  • You have access
    Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
    TOMOMI SANOMACHI, SHUHEI SUZUKI, KEITA TOGASHI, SHIZUKA SEINO, TAKASHI YOSHIOKA, CHIFUMI KITANAKA, MASASHI OKADA and MASAHIRO YAMAMOTO
    Anticancer Research September 2019, 39 (9) 4817-4828; DOI: https://doi.org/10.21873/anticanres.13667
  • You have access
    Down-regulation of Survivin by BIX-01294 Pretreatment Overcomes Resistance of Hepatocellular Carcinoma Cells to TRAIL
    YENA NAMGUNG, SO YOUNG KIM and INKI KIM
    Anticancer Research July 2019, 39 (7) 3571-3578; DOI: https://doi.org/10.21873/anticanres.13503
  • You have access
    Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial–Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy
    JIYOUNG KIM, SOOMIN AHN, KYUBO KIM, MIN SUN CHO, KWANG HO KIM, RYUNG-AH LEE and EUN MI NAM
    Anticancer Research December 2018, 38 (12) 6881-6889; DOI: https://doi.org/10.21873/anticanres.13064
  • You have access
    Investigation of Survivin Gene Polymorphism and Serum Survivin Levels in Patients with Brain Tumors
    DIDEM KAFADAR, ILHAN YAYLIM, ALI METIN KAFADAR, CANAN CACINA, ARZU ERGEN, MEHMET YASAR KAYNAR and TURGAY ISBIR
    Anticancer Research October 2018, 38 (10) 5991-5998; DOI: https://doi.org/10.21873/anticanres.12947
  • You have access
    Inhibition of Survivin by Adenovirus Vector Enhanced Paclitaxel-induced Apoptosis in Breast Cancer Cells
    TOSHIHIRO TANAKA and HIROAKI UCHIDA
    Anticancer Research July 2018, 38 (7) 4281-4288; DOI: https://doi.org/10.21873/anticanres.12725
  • You have access
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin
    YOON JUNG KIM, HYO-JEONG HWANG, JUN GOO KANG, CHUL SIK KIM, SUNG-HEE IHM, MOON GI CHOI and SEONG JIN LEE
    Anticancer Research June 2018, 38 (6) 3515-3525; DOI: https://doi.org/10.21873/anticanres.12623
  • You have access
    Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation
    MADHURA PATANKAR, SARA VÄYRYNEN, ANNE TUOMISTO, MARKUS MÄKINEN, SINIKKA ESKELINEN and TUOMO J. KARTTUNEN
    Anticancer Research May 2018, 38 (5) 2915-2921;
  • You have access
    Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy
    KOZO YOSHIKAWA, MITSUO SHIMADA, JUN HIGASHIJIMA, TOSHIHIRO NAKAO, MASAAKI NISHI, CHIE TAKASU, HIDEYA KASHIHARA, SYOHEI ETO and YOSHIMI BANDO
    Anticancer Research March 2018, 38 (3) 1735-1739;
  • You have access
    Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment
    JASMINE M. MANOUCHEHRI and MICHAEL KALAFATIS
    Anticancer Research December 2017, 37 (12) 6593-6599;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire